Table 1.
Baseline characteristics, history, and medication in hospital between the two groups
| Items | Aspirin group (n = 139) | No-aspirin group (n = 249) | t or χ2 | P |
|---|---|---|---|---|
| Age (years) | 57.0 ± 10.3 | 52.5 ± 11.9 | 3.812* | <0.001 |
| Male, n (%) | 114 (82.0) | 196 (78.7) | 0.605 | 0.437 |
| Smoker, n (%) | 79 (56.8) | 158 (63.5) | 1.644 | 0.200 |
| Drinker, n (%) | 47 (36.4) | 96 (38.6) | 0.162 | 0.687 |
| Hypertension, n (%) | 128 (92.1) | 209 (83.9) | 5.191 | 0.023 |
| Diabetes, n (%) | 10 (7.2) | 7 (2.8) | 4.090 | 0.043 |
| Cerebrovascular diseases | ||||
| Hemorrhage, n (%) | 2 (1.4) | 8 (3.2) | 0.523 | 0.470 |
| Ischemia, n (%) | 18 (12.9) | 20 (8.0) | 2.442 | 0.118 |
| Peripheral vascular disease, n (%) | 1 (0.7) | 1 (0.4) | 0.112 | 0.749 |
| Digestive diseases, n (%) | 9 (6.5) | 11 (4.4) | 0.772 | 0.380 |
| SBP (mmHg) | 155.96 ± 28.46 | 156.00 ± 26.08 | 0.014* | 0.989 |
| PR (beats/min) | 81.99 ± 15.50 | 83.34 ± 15.75 | 0.814* | 0.416 |
| Medication in hospital | ||||
| ACEI, n (%) | 118 (84.9) | 210 (84.3) | 0.021 | 0.885 |
| ARB, n (%) | 58 (41.7) | 87 (34.9) | 1.756 | 0.185 |
| β-blockers, n (%) | 133 (95.7) | 236 (94.8) | 0.157 | 0.692 |
| CCB, n (%) | 132 (95.7) | 233 (93.6) | 0.309 | 0.578 |
| Diuretics, n (%) | 54 (38.8) | 93 (37.3) | 0.085 | 0.770 |
| Statins, n (%) | 73 (52.5) | 54 (21.7) | 38.511 | <0.001 |
*t values. PR: Pulse rate; SBP: Systolic blood pressure; ACEI: Angiotensin-converting enzyme inhibitor; ARB: Angiotensin receptor blocker; CCB: Calcium channel blocker.